Stocktoria
CASTLE BIOSCIENCES INC CSTL
CASTLE BIOSCIENCES INC financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $344.2M | $332.1M | $219.8M | $137.0M | $94.1M | $62.6M | $51.9M | $22.8M |
| Gross profit | — | — | — | — | — | $53.0M | $44.6M | $17.5M |
| R&D expense | $51.9M | $52.0M | $53.6M | $44.9M | $29.6M | $13.3M | $7.4M | $4.9M |
| SG&A expense | $229.3M | $200.0M | $180.2M | $143.0M | $86.7M | $48.1M | $29.8M | $16.5M |
| Operating income | -$42.8M | $8.7M | -$68.0M | -$72.9M | -$40.1M | -$6.5M | $7.3M | -$3.8M |
| Interest expense | — | — | $11,000 | $17,000 | $1,000 | $2.6M | $4.6M | $2.3M |
| Income tax | -$5.4M | $3.3M | $101,000 | -$1.8M | -$8.7M | $84,000 | $72,000 | $9,000 |
| Net income | -$24.2M | $18.2M | -$57.5M | -$67.1M | -$31.3M | -$10.3M | $5.3M | -$6.4M |
| EPS (diluted) | $-0.83 | $0.62 | $-2.14 | $-2.58 | $-1.24 | $-0.54 | $-0.21 | $-5.33 |
| Operating cash flow | $64.3M | $64.9M | -$5.6M | -$41.7M | -$19.0M | $9.9M | $7.0M | -$12.3M |
| Free cash flow | $28.3M | $36.5M | -$19.2M | -$47.3M | -$22.5M | $5.1M | $6.1M | -$12.6M |
| Cash & equivalents | $116.7M | $119.7M | $98.8M | $122.9M | $329.6M | $409.9M | $98.8M | $4.5M |
| Inventory | $10.3M | $8.1M | $7.9M | $4.0M | $2.0M | $2.2M | $1.2M | $882,000 |
| Total assets | $578.6M | $531.2M | $453.3M | $447.3M | $462.6M | $439.3M | $119.7M | $22.4M |
| Total liabilities | $107.7M | $75.4M | $62.1M | $48.2M | $50.8M | $23.6M | $34.6M | $32.5M |
| Shareholders' equity | $470.9M | $455.8M | $391.3M | $399.1M | $411.7M | $415.7M | $85.1M | -$56.6M |
Growth · year-over-year · Revenue CAGR 47.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +3.7% | +51.1% | +60.4% | +45.7% | +50.2% | +20.8% | +127.6% | — |
| Net income growth | -232.4% | — | — | — | — | -294.9% | — | — |
| EPS growth | -233.9% | — | — | — | — | — | — | — |
| Free cash flow growth | -22.5% | — | — | — | -539.3% | -15.9% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.